All Posts Tagged With: "coronary bypass"
Trasylol Increases the Risk of Death
Use of the blood-saving drug aprotinin (Trasylol) during coronary bypass surgery significantly increases the risk of death, according to data from two large studies.
Patients treated with aprotinin had an almost a two-fold greater mortality compared with patients given aminocaproic acid during heart surgery, Sebastian Schneeweiss, M.D., Sc.D., of Harvard, and colleagues, reported in the Feb. [...]
Popularity: 43% [?]
26Feb2008 | PharmaWatchDog | 0 comments | Continued
